Voluntary clinical trials

Explore recruiting voluntary clinical trials.

Recruiting voluntary studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Voluntary trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Investigate the Efficacy and Safety of Once Daily Mexiletine PR During 26 Weeks of Treatment in Patients with Myotonic Dystrophy Type 1 and Type 2

Germany, Denmark, Italy, Belgium, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Clinical safety study on 5-Aminolevulinic acid (5-ALA) in children and adolescents with brain tumors (5-ALA in children and adolescents)

Germany, Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

EPITOPE Open-label Extension Study to Evaluate the Long-term Clinical Benefit and Safety of DBV712 in Peanut-Allergic Children (EPOPEX)

Germany, Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

BIGTIM: Blocking Interferon-γ by ruxolitinib for Treating Inclusion body Myositis: a phase IIb trial.

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Immediate versus delayed insertion of intrauterine contraception at the time of medical abortion- An open-label, randomized, multicenter study

Sweden

Therapeutic confirmatory (Phase III) EU CTIS Study details

Single-arm, open-label dose titration phase 2 clinical trial of (+)-α-DHTBZ for the treatment of tardive dyskinesia (TD)

Croatia

Therapeutic exploratory (Phase II) EU CTIS Study details

Voluntary trials by city

Voluntary in Toronto Voluntary in Vancouver Voluntary in Montreal Voluntary in Calgary Voluntary in Edmonton Voluntary in Ottawa Voluntary in Winnipeg Voluntary in Quebec City Voluntary in Hamilton Voluntary in Kitchener Voluntary in London Voluntary in Halifax Voluntary in New York Voluntary in Los Angeles Voluntary in Chicago Voluntary in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease